Table 3.

Univariate analysis of 30 days mortality, complications and 1 year mortality.

	n	30 days mortality	p	Complications*	p	1 year mortality	p
Sex			0.16		0.37		0.07
Female	48	0%		31.3%		10.4%
Male	100	4%		38.8%		23.0%
Age			0.02		0.002		<0.001
< 70 years	86	0%		25.9%		9.3%
≥ 70 years	62	6.5%		50.8%		32.3%
Preoperative stage			0.09		0.18		0.04
IA (T1 N0 M0)	64	0%		31.3%		10.9%
IB (T2 N0 M0)	68	5.9%		36.4%		22.1%
II-IV	16	0%		56.3%		37.5%
Operation type			0.001		0.29		0.11
Lobectomy	97	0%		31.3%		15.5%
Pneumonectomy	30	13.3%		46.7%		33.3%
Bilobectomy	16	0%		40%		18.8%
Wedge	5	0%		60%		0%
Histology			0.57		0.35		0.21
Adenocarcinoma	73	1.4%		33.3%		13.7%
Squamous cell carcinoma	53	3.8%		42.3%		22.6%
Large cell carcinoma	14	7.1%		42.9%		35.7%
Other non-small cell carcinoma	8	0%		12.5%		12.5%
Coronary heart disease			0.03		0.84		0.91
No previous coronary disease	107	0.9%		36.8%		18.7%
Previous coronary disease	41	7.3%		35.0%		19.5%
Pulmonary function			0.22		0.40		0.86
FEV1 ≥ 80%	62	4.8%		33.9%		19.4%
FEV1<80%	77	1.3%		40.8%		18.2%

Statistical analysis: χ2.

*Two patients excluded because of insufficient information.